Alcoa (NYSE:AA) has agreed to acquire South32's global bauxite, alumina, and aluminum operations, in a transaction that reshapes its upstream portfolio.
The deal expands Alcoa's footprint across key regions including Australia, Brazil, and South Africa.
The acquisition is described as immediately accretive to earnings and cash flow for Alcoa.
For investors tracking Alcoa at a share price of $47.48, this transaction follows a mixed period for the stock, with a decline of 38.9% over the past...
SEALSQ stock has been weak over a three year window, with investors seeing a steep decline in that period, while the latest valuation checks suggest the shares still screen as expensive rather than a clear bargain.
Over the past 3 years, SEALSQ has fallen about 78%, which means anyone who held through that stretch has seen substantial capital erosion that now frames how current pricing is judged.
Excitement around SEALSQ's post quantum security offerings and expansion into areas like...
Honeywell Aerospace completed its spin off from Honeywell International and is now an independent company.
The company began trading on the Nasdaq under the ticker NasdaqGS:HONA.
The spin off has led to index inclusions such as the S&P 500, NASDAQ Composite, Russell 1000, and FTSE All World.
Honeywell Aerospace reports a backlog above US$19b and is targeting aerospace supply chain expansion as a standalone entity.
Honeywell Aerospace, now listed as NasdaqGS:HONA, operates at the center of...
NRG Energy stock has delivered a very strong return over the past three years, yet the current valuation checks still suggest the shares screen as undervalued on several fronts. This raises a clear question about how much of that past performance is already reflected in the price.
Over the past three years, NRG Energy has returned about 290%, which puts recent short term weakness into context and raises the issue of whether the longer term rerating has gone too far or not far enough.
For...
FIGS, Inc. (NYSE:FIGS) has been added to the Russell 2000 Growth-Defensive Index.
The company has also been included in the Russell 2000 Defensive Index.
These index additions are described as recent and apply to FIGS shares going forward.
FIGS, known for its healthcare apparel and scrubwear, now sits inside two widely followed Russell 2000 defensive benchmarks. For a company that focuses on medical professionals and essential workwear, this new index presence may matter for how investors...
Carlisle Companies (NYSE:CSL) was dropped from three Russell 1000 indices: Value Defensive, Defensive, and Growth Defensive, effective June 27, 2026.
The change alters Carlisle's index footprint, which can influence passive fund ownership and how the stock is grouped with defensive or growth peers.
Carlisle Companies now sits outside several Russell 1000 defensive style indices just as the stock trades around $360.85. The shares are up 6.5% over the past 30 days and 9.9% year to date, but...
Biogen stock has delivered a strong 57.5% return over the past year, yet the broader valuation checks suggest the shares now look closer to fairly priced than clearly cheap.
Over the last 12 months, Biogen has returned 57.5%, which puts more pressure on today’s buyers to justify the higher entry point with future execution.
Progress on newer therapies for Alzheimer’s disease and other conditions can support expectations for future cash flows. However, setbacks in clinical trials and legal...
Apollo Commercial Real Estate Finance (ARI) has been dropped from several major equity benchmarks, including the Russell 2000 Growth, S&P Composite 1500, and S&P 600 indices, prompting investors to reassess index driven demand for the stock.
See our latest analysis for Apollo Commercial Real Estate Finance.
Against the index removals backdrop, Apollo Commercial Real Estate Finance’s share price has eased in the short term, with a 1-day share price return of 1.31% down and a 30-day share price...
In late June 2026, Palantir Technologies and Surf Air Mobility expanded their partnership to accelerate the development and commercialization of SurfOS aviation software suites, while Surf Air Mobility also launched an electric aircraft demonstration program in Hawai‘i with BETA Technologies and Hawaiian Airlines to test future regional cargo and passenger operations.
Together, these moves position Surf Air Mobility at the intersection of AI-enabled aviation software and low-emission...
Jack in the Box (JACK) has suddenly moved back onto investor radar after a sharp rally tied to a $500 million debt refinancing, heavy short covering, and fresh inclusions in several Russell equity indices.
See our latest analysis for Jack in the Box.
At a share price of $17.41, Jack in the Box has seen sharp short term momentum, with a 30 day share price return of 29.15% and a 90 day return of 74.27%. However, the 1 year total shareholder return is down 15.44% and the 5 year total shareholder...
Unicycive Therapeutics (UNCY) is back in focus after the US Food and Drug Administration issued a Complete Response Letter on its resubmitted New Drug Application for oxylanthanum carbonate, keeping approval on hold over third party manufacturing issues.
See our latest analysis for Unicycive Therapeutics.
The FDA letter and the recent expansion of Unicycive Therapeutics' at-the-market program have coincided with sharp share price swings, including a 12.58% 1-day share price return, but 7-day...
Rising rate expectations, persistent inflation pressures, and a less predictable Federal Reserve are reshaping how investors think about US regional banks. With markets now entertaining the idea of rate hikes instead of cuts, the way these banks price loans, manage deposits, and handle funding costs is back in focus. This article walks through three regional bank stocks from our US Regional Banks screener that are closely tied to the current policy debate and economic backdrop. By the end,...
Virtuix stock gains another defense catalyst as its Air National Guard deployment strengthens the case for broader military adoption and future revenue growth.
Crinetics Pharmaceuticals recently presented Phase 2 TouCAHn data showing atumelnant reduced glucocorticoid doses while maintaining androgen control in classic congenital adrenal hyperplasia, and shared two-year PALSONIFY (paltusotine) data in acromegaly indicating maintained disease control and tolerability, while also scheduling its second-quarter 2026 earnings release and business update call for August 4, 2026.
Together, these clinical updates highlight Crinetics’ progress in rare...
Supply chain disruptions are doing more than keeping shelves patchy; they are reshaping pricing power across logistics, shipping, ports, and storage. When goods are harder to replace, companies that move and manage them can sometimes set terms instead of just accepting them, while weaker operators risk being squeezed by higher costs and lost volumes. This article looks at three stocks from a Supply Chain Infrastructure and Logistics Companies screener that are closely tied to these pressures...
Abacus Global Management (ABX) drew investor attention after its stock gained 7.3% in the latest session, following a federal court decision that denied Coventry First's motion to dismiss Abacus's defamation lawsuit.
See our latest analysis for Abacus Global Management.
That legal win slots into a strong recent run for Abacus Global Management, with a 30 day share price return of 29.06% and a 1 year total shareholder return of 125.86%, suggesting momentum has been building for some time.
If...
